Journal of Biological Chemistry · 2010 · 45 citations · 37 references
Life SciencesBiochemistryMolecular BiologyCell SignalingMembrane TraffickingSignal TransductionEndomembrane SystemLipid SignalingPhosphoinositide SignalingProtozoan PathogenesisExtracellular DomainsPhosphoinositide BindingPhosphoinositide-binding DomainsPlasma Membrane ContributionTrypanosoma Cruzi InfectionTrypanosoma Cruzi Life Cycle
Phosphoinositide phospholipase C (PI-PLC) plays an essential role in cell signaling. A unique Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid-modified in its N terminus and localizes to the plasma membrane of amastigotes. Here, we show that TcPI-PLC is located onto the extracellular phase of the plasma membrane of amastigotes and that its N-terminal 20 amino acids are necessary and sufficient to target the fused GFP to the outer surface of the parasite. Mutagenesis of the predicted acylated residues confirmed that myristoylation of a glycine residue in the 2nd position and acyl modification of a cysteine in the 4th but not in the 8th or 15th position of the coding sequence are required for correct plasma membrane localization in T. cruzi epimastigotes or amastigotes. Interestingly, mutagenesis of the cysteine at the 8th position increased its flagellar localization. When expressed as fusion constructs with GFP, the N-terminal 6 and 10 amino acids fused to GFP are predominantly located in the cytosol and concentrated in a compartment that co-localizes with a Golgi complex marker. The N-terminal 20 amino acids of TcPI-PLC associate with lipid rafts when dually acylated. Taken together, these results indicate that N-terminal acyl modifications serve as a molecular addressing system for sending TcPI-PLC to the outer surface of the cell.
37
Frederick S. Buckner, Christophe L. M. J. Verlinde, Anne Camille La Flamme et al. · Antimicrobial Agents and Chemotherapy · 1996 · 540 citations · Full text
Richard E. Pagano, Ona C. Martin, Hoon‐Chul Kang et al. · The Journal of Cell Biology · 1991 · 492 citations · Full text
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Julie A. Frearson, Stephen Brand, Stuart P. McElroy et al. · Nature · 2010 · 311 citations · Full text